In a significant move, video-conferencing giant Zoom has partnered with AI medical scribe startup Suki to offer doctors on its platform an AI-powered note-taking tool. This integration is set to transform the telehealth landscape, saving doctors valuable time and streamlining medical records.

With Zoom dominating the telehealth space, accounting for 36% of all U.S. telehealth visits, this partnership is poised to have a substantial impact. Suki, which recently closed a $70 million Series D funding round, was chosen by Zoom after a thorough evaluation of other AI medical scribe startups.

This development is part of Zoom's broader strategy to shift its focus from conferencing to AI-powered workplace tools. Meanwhile, Amazon-owned One Medical is also investing in AI tools to aid clinicians, leveraging its in-house Bedrock and AWS HealthScribe services.

The AI medical scribe market is booming, with startups like Abridge, Nabla, and Ambiance Healthcare making waves. Investors are bullish on the space, citing the significant time-saving benefits for healthcare providers. While there are concerns about the potential threat from general-purpose foundational models, industry insiders believe the current crop of startups has sufficient differentiation to thrive.